LEANNA BABB: Open Payments
NPI 1366069536 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 20 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $173 |
| Madrigal Pharmaceuticals | 3 | $164 |
| Janssen Biotech, Inc. | 5 | $115 |
| ABBVIE INC. | 2 | $29 |
| GENZYME CORPORATION | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
Products named: REZDIFFRA, ENTYVIO, TREMFYA, EOHILIA, RINVOQ, DUPIXENT, OCALIVA, ZENPEP.
Industry payments across AZ — which companies pay providers there.
